Liminatus Pharma Inc (LIMN)

$8.04 -2.03 (-20.16%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 96,300
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the potential to translate into clinic for CD47 SIRPa blocking and restoring the anti-tumor function of innate immune cells without inducing hemagglutination or hemolysis. The company was founded in 2018 is based in LA Palma, California.

Industry: Biotechnology
Sector: Healthcare
Phone: 213 273 5453
Address:
6 Centerpointe Drive, #625, La Palma, United States
PrettyKitty
PrettyKitty Mar. 18 at 3:31 PM
$LIMN ❤️
0 · Reply
cjwashington
cjwashington Mar. 18 at 1:28 PM
$LIMN
0 · Reply
StockNews_Live
StockNews_Live Mar. 17 at 1:17 PM
$LIMN 🎯 STOCK NEWS ALERT 💵 Price: $0.24 (+1.20%) 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Liminatus announced plans to initiate a Phase 1 clinical trial evaluating IBA101, a next-generation CD47-blocking monoclonal antibody designed to engage innate immune pathways and complement… 📎 https://stocknews.live/news/LIMN/liminatus-pharma-announces-planned-59359.html
0 · Reply
einada
einada Mar. 17 at 12:45 PM
$LIMN what bullshit PM crap price action going on?!!
0 · Reply
DARKP00L
DARKP00L Mar. 17 at 12:26 PM
$LIMN 08:14 on Mar. 17 2026 Liminatus Intends To Start Phase 1 Clinical Study Of CD47-Blocking Monoclonal Antibody #tradeideas
0 · Reply
Tracey11
Tracey11 Mar. 17 at 12:15 PM
$LIMN Maybe not
0 · Reply
RedHottie
RedHottie Mar. 17 at 12:11 PM
$LIMN https://www.moomoo.com/news/post/66988475?ns_stock_id=86792699365483&report_type=stock&report_id=59487484&main_broker=WwogIDEwMDcKXQ%3D%3D&skintype=3&src=2&stock_news_tab=news&us_cid=72235814&futusource=news_stock_stockpagenews&client_hour_clock=24&level=1&global_content=%7B%22promote_content%22%3A%22mm%3Apost%3A66988475%22%2C%22invite%22%3A72235814%7D&data_ticket=763c2105711fcc952dcd232f38e29bb4
0 · Reply
Tracey11
Tracey11 Mar. 17 at 12:11 PM
$LIMN 🤨
0 · Reply
Stock_Catcher
Stock_Catcher Mar. 17 at 12:08 PM
$LIMN Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody
0 · Reply
TheTradeXchange
TheTradeXchange Mar. 17 at 12:08 PM
$LIMN - Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody
0 · Reply
Latest News on LIMN
Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody

Mar 17, 2026, 8:08 AM EDT - 1 day ago

Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody

Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering

Feb 17, 2026, 8:44 AM EST - 4 weeks ago

Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering

Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation

Oct 30, 2025, 10:04 AM EDT - 4 months ago

Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation

Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary and Target Up To $500 Million Fund for BNB Investment as Part of Crypto Market Initiative

Jul 28, 2025, 7:30 AM EDT - 8 months ago

Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary and Target Up To $500 Million Fund for BNB Investment as Part of Crypto Market Initiative

Liminatus Pharma Inc. Evaluates Formation of Digital Asset Investment Vehicle Targeting Up To $500 Million in Capital Strategies

Jul 25, 2025, 8:31 AM EDT - 8 months ago

Liminatus Pharma Inc. Evaluates Formation of Digital Asset Investment Vehicle Targeting Up To $500 Million in Capital Strategies

Liminatus Pharma Inc. Takes Next Step in Evaluating Digital Asset-Linked Capital Strategy

Jul 24, 2025, 8:31 AM EDT - 8 months ago

Liminatus Pharma Inc. Takes Next Step in Evaluating Digital Asset-Linked Capital Strategy

Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury Strategy

Jul 22, 2025, 1:30 PM EDT - 8 months ago

Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury Strategy

PrettyKitty
PrettyKitty Mar. 18 at 3:31 PM
$LIMN ❤️
0 · Reply
cjwashington
cjwashington Mar. 18 at 1:28 PM
$LIMN
0 · Reply
StockNews_Live
StockNews_Live Mar. 17 at 1:17 PM
$LIMN 🎯 STOCK NEWS ALERT 💵 Price: $0.24 (+1.20%) 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Liminatus announced plans to initiate a Phase 1 clinical trial evaluating IBA101, a next-generation CD47-blocking monoclonal antibody designed to engage innate immune pathways and complement… 📎 https://stocknews.live/news/LIMN/liminatus-pharma-announces-planned-59359.html
0 · Reply
einada
einada Mar. 17 at 12:45 PM
$LIMN what bullshit PM crap price action going on?!!
0 · Reply
DARKP00L
DARKP00L Mar. 17 at 12:26 PM
$LIMN 08:14 on Mar. 17 2026 Liminatus Intends To Start Phase 1 Clinical Study Of CD47-Blocking Monoclonal Antibody #tradeideas
0 · Reply
Tracey11
Tracey11 Mar. 17 at 12:15 PM
$LIMN Maybe not
0 · Reply
RedHottie
RedHottie Mar. 17 at 12:11 PM
$LIMN https://www.moomoo.com/news/post/66988475?ns_stock_id=86792699365483&report_type=stock&report_id=59487484&main_broker=WwogIDEwMDcKXQ%3D%3D&skintype=3&src=2&stock_news_tab=news&us_cid=72235814&futusource=news_stock_stockpagenews&client_hour_clock=24&level=1&global_content=%7B%22promote_content%22%3A%22mm%3Apost%3A66988475%22%2C%22invite%22%3A72235814%7D&data_ticket=763c2105711fcc952dcd232f38e29bb4
0 · Reply
Tracey11
Tracey11 Mar. 17 at 12:11 PM
$LIMN 🤨
0 · Reply
Stock_Catcher
Stock_Catcher Mar. 17 at 12:08 PM
$LIMN Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody
0 · Reply
TheTradeXchange
TheTradeXchange Mar. 17 at 12:08 PM
$LIMN - Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody
0 · Reply
cjwashington
cjwashington Mar. 16 at 6:10 PM
$LIMN
0 · Reply
i_like_bb_stock
i_like_bb_stock Mar. 16 at 4:00 PM
$LIMN perking over .25 might get some juice still think we see a nice move coming been in tight range for a few weeks
0 · Reply
Cemilio
Cemilio Mar. 16 at 3:59 PM
$LIMN ❤️
0 · Reply
einada
einada Mar. 16 at 3:09 PM
$LIMN don’t tell me another F boring day! MOVEEEEE!!!!!
0 · Reply
einada
einada Mar. 13 at 3:50 PM
$LIMN what a boring ticker
0 · Reply
cjwashington
cjwashington Mar. 13 at 2:05 PM
$LIMN
0 · Reply
griffygriff3
griffygriff3 Mar. 12 at 10:39 PM
$LIMN Damm this seller is annoying!
0 · Reply
TwoToesTrading
TwoToesTrading Mar. 12 at 8:55 PM
$LIMN 👀
1 · Reply
Kewlpapa
Kewlpapa Mar. 12 at 8:06 PM
$LIMN picked up a starter here
0 · Reply
i_like_bb_stock
i_like_bb_stock Mar. 12 at 4:19 PM
$LIMN HOD continues to trade in a super tight range here selling has stopped just a matter of enough buying to move it theres also a gap fill ahead all ingredients for a run
1 · Reply
cjwashington
cjwashington Mar. 12 at 4:12 PM
$LIMN mm's needs to take the finger off the hold button, come on let's go
1 · Reply
yolobuffett
yolobuffett Mar. 12 at 1:39 PM
$LIMN any hope with this one?
0 · Reply